June 11, 2025

PPV Glaucoma Risk

Study observes risk of pars plana vitrectomy patients developing glaucoma within five years of procedure

The Ophthalmologist

June 02, 2025

Optical Coherence Tomography Angiography and Glaucoma

A patient with a history of LASIK and glaucoma receives treatment with latanoprost despite challenges in adjusting intraocular pressure due to corneal thinning post-refractive surgery. Optic nerve and macular thinning, visual field defects, and perfusion loss raise concerns for long-term prognosis.

Optometric Management

June 01, 2025

Unlocking Uveoscleral Outflow: A New Path Awaits Post-MIGS

Many MIGS patients experience a gradual loss of IOP control over time, which after years of increasing medication burden often leads to discussions about bleb-forming procedures. In our limited control release experience with AlloFlo Uveo, surgeons have identified a new option to help these patients without leaving the angle or sacrificing the conjunctiva.

Glaucoma Physician

June 01, 2025

Strategies for Successful Glaucoma Comanagement

Glaucoma management is a lifelong endeavor that requires consistent monitoring, timely intervention, and patient adherence. Comanagement of glaucoma involving optometrists and ophthalmologists has emerged as a highly effective approach that can enhance patient outcomes, streamline care delivery, and foster professional satisfaction for both providers.

Glaucoma Physician

June 01, 2025

Managing Cataract After Standalone MIGS

As the glaucoma treatment paradigm shifts, surgeons will increasingly encounter patients who previously underwent standalone MIGS and later present for cataract surgery. This scenario raises a few considerations regarding optimal intraoperative planning and long-term IOP management. This article outlines a practical framework for surgical planning and decision-making in this unique population.

Glaucoma Physician

June 01, 2025

Study Associates Interferon Beta with Glaucoma Risk

Patients with primary glaucoma may exhibit significantly lower levels of endogenous intraocular interferon beta (IFN-β) compared to individuals without the disease, according to a study published this week in the Journal of Ocular Pharmacology and Therapeutics.

Glaucoma Physician

June 01, 2025

Consensus Builds for Interventional Glaucoma

Christine Funke, MD, and Deborah Ristvedt, DO, discuss a newly published interventional glaucoma (IG) consensus treatment protocol. They explain how it was developed, suggest strategies for implementation in clinics and surgical centers, and reflect on what IG will mean for glaucoma management moving forward.

Glaucoma Physician

June 01, 2025

POAG Diagnosis May Impact Mental Health

Patients diagnosed with primary open-angle glaucoma (POAG) may experience a measurable decline in self-reported mental health after learning about their disease, even in the absence of notable changes in clinical vision or visual function, according to a cohort study published recently in JAMA Ophthalmology.

Glaucoma Physician

May 23, 2025

BP Pills: Does Timing Matter? 

A large Canadian study of 3,357 patients found that taking blood pressure medication at bedtime did not reduce deaths or heart events compared to morning dosing.

Conexiant